共查询到20条相似文献,搜索用时 15 毫秒
1.
S. Di Donato 《The Italian Journal of Neurological Sciences》1998,19(6):335-343
The clinical classification of autosomal dominant cerebellar ataxias (ADCAs) is intricate due to the variable and unpredictable
association of signs and symptoms of central nervous system (CNS) and peripheral nervous system (PNS) deterioration during
the life of a patient. However, for many purposes, particularly patient management, clinical systematics is the most useful
method for labelling patients; in some instances there is no basis for any more fundamental classification of phenotypes.
On the other hand, recent molecular-genetic approaches to dominant ataxias have had a profound impact in nosology, diagnostic
procedures and the management of patients, since they are based on the fact that all mendelian neurological diseases can be
precisely classified according to the locus involved as well as the particular mutant allele at that locus. Therefore, a clinical
and genetic classification of dominant ataxias is herewith proposed as the best nosographical choice. Clinical, neuropathological,
genetic, and pathogenetic aspects of ADCAs are reviewed and discussed to help the clinical neurologist guide diagnostic procedures
and manage ataxic patients.
Sommario La classificazione clinica delle atassie cerebellari dominanti autosomiche (ADCA) è intrinsecamente complessa poiché i segni e i sintomi di sofferenza del sistema nervoso centrale e periferico si associano in modo variabile e spesso imprevedibile durante la vita dei pazienti affetti da diverse forme dominanti di atassia. Tuttavia, in assenza di criteri più stringenti per una precisa nosografia, una distinzione semiologica basata sui principali segni clinici è il metodo più utile per un primo inquadramento diagnostico dei malati. Le informazioni di genetica molecolare ottenute recentemente nelle atassie dominanti hanno modificato questa pur utile nosografia, perché portano il contributo di un dato biologico fondamentale consistente nel fatto the ogni malattia ereditaria può essere precisamente classificata sulla base sia del locus genetico coinvolto sia della mutazione eziologicamente responsabile. Sulla base di queste semplici considerazioni si propone una classificazione clinica e genetica delle atassie dominanti. I principali aspetti clinici, neuropatologici, genetici, sono presentati insieme ad una discussione sugli aspetti patogenetici delle ADCA per fornire al neurologo clinico una guida razionale e aggiornata ally diagnosi e alla gestione dei pazienti con atassia.相似文献
2.
This paper reviews and summarizes three main aspects of spinocerebellar ataxias (SCA) in the Asian population. First, epidemiological studies were comprehensively reviewed. Overall, the most common subtypes include SCA1, SCA2, SCA3, and SCA6, but there are large differences in the relative prevalence of these and other SCA subtypes between Asian countries. Some subtypes such as SCA12 and SCA31 are rather specific to certain Asian populations. Second, we summarized distinctive phenotypic manifestations of SCA patients of Asian origin, for example a frequent co-occurrence of parkinsonism in some SCA subtypes. Lastly, we have conducted an exploratory survey study to map SCA-specific expertise, resources, and management in various Asian countries. This showed large differences in accessibility, genetic testing facilities, and treatment options between lower and higher income Asian countries.Currently, many Asian SCA patients remain without a final genetic diagnosis. Lack of prevalence data on SCA, lack of patient registries, and insufficient access to genetic testing facilities hamper a wider understanding of these diseases in several (particularly lower income) Asian countries. 相似文献
3.
S. Sorbi S. Piacentini C. Fani S. Tonini P. Marini L. Amaducci 《Acta neurologica Scandinavica》1989,80(2):103-110
The activity of 7 mitochondrial enzymes, fumarase, NAD-malate dehydrogenase (MDH), citrate synthase (CS), valine dehydrogenase (VDH), succinate dehydrogenase (SDH), glutamate dehydrogenase (GDH), pyruvate dehydrogenase complex (PDHC) has been measured in platelet preparations from patients affected by Friedreich's ataxia (FA), dominant and non-dominant olivopontocerebellar atrophy (DOPCA, NDOPCA) and normal individuals. Significant decreases of GDH (P less than 0.01), PDHC (P less than 0.01), VDH (P less than 0.05) and SDH (P less than 0.05) activities were observed in FA patients. Significant decreases of GDH (P less than 0.01), PDHC (P less than 0.01), VDH (P less than 0.05), SDH (P less than 0.05) and CS (P less than 0.05) activities were Observed in ND-OPCA patients, whereas in DOPCA patients only GDH activity was significantly (P less than 0.05) decreased. In 8 of 10 patients with FA and in all patients with NDOPCA the activity of one or more of 4 enzymes, i.e. GDH, VDH, SDH, PDHC, was lower than the lowest of control values. Four of 6 patients with DOPCA had GDH activity lower than the lowest of control values. These results indicate that abnormalities of mitochondrial metabolism is a constant element in hereditary ataxia and suggest that the alteration primary leading to the different types of ataxias should be related to mitochondrial oxidative metabolism, at least at a regulatory level. 相似文献
4.
Roberto Rodríguez-Labrada Luis Velázquez-Pérez Ulf Ziemann 《Clinical neurophysiology》2018,129(8):1688-1698
Transcranial magnetic stimulation (TMS) is a valuable technique to assess and modulate human brain function in normal and pathological conditions. This critical review surveys the contributions of TMS to the diagnosis, insight into pathophysiology and treatment of genetically confirmed hereditary ataxias, a heterogeneous group of neurodegenerative disorders that can affect motor cortex and the corticospinal tract. Most studies were conducted on small sample sizes and focused on diagnostic approaches. The available data demonstrate early involvement of the corticospinal tract and motor cortex circuitry, and support the possible efficacy of cerebellar repetitive TMS (rTMS) as therapeutic approach. Further TMS-based studies are warranted, to establish biomarkers for early diagnosis and disease monitoring, explore the involvement of the cerebello-dentato-thalamo-cortical projection, study the effects of rTMS-induced plasticity, and utilize rTMS for treatment. 相似文献
5.
遗传性脊髓小脑型共济失调6型两个家系的临床特征及基因突变研究 总被引:5,自引:0,他引:5
目的 研究中国人遗传性脊髓小脑型共济失调6型(SCA6)的基因突变和临床特征。方法 应用聚合酶链反应(PCR)、聚丙烯酰胺凝胶电泳(PAGE)等技术,检测临床诊断脊髓小脑型共济失调(SCA)的120个家系210例患者和47例散发SCA患者的SCA6基因内CAG三核苷酸重复序列,并对异常等位基因片段进行DNA测序。结果 检出2个家系(4例患者)为SCA6,阳性率为1,7%,测序证实其异常等位基因的CAG重复数目为25和26。另253例SCA患者的SCA6等位基因CAG重复数目为7-17,健康人SCA6等位基因CAG重复数目为5-16。2个家系均存在遗传早现现象,异常扩展的CAG序列呈代间稳定性。结论 从临床及基因诊断方面首次确认中国大陆存在SCA6家系;CAG过度扩增为SCA6的致病原因。 相似文献
6.
目的研究中国大陆南方正常人群齿状核红核苍白球路易体萎缩(DRPLA)基因(以CAG)n正常变异范围,以及DRPLA基因(CAG)n扩展突变在中国大陆脊髓小脑型共济失调(SCA)患者中的分布。方法应用荧光PCR,毛细管电泳等技术,对67个已经排除了SCA1、SCA2、SCA3、SCA6、SCA7的常染色体显性遗传SCA家系的先证者和66个散发SCA患者以及94个南方正常汉族人进行DRPLA基因CAG重复次数分析。结果未发现DRPLA基因(CAG)n扩展突变;DRPLA基因(CAG)n正常变异范围为5~21个拷贝,15个拷贝最多见,杂合频率为89.13%,共14种等位基因。结论DRPLA在中国大陆为罕见的SCA亚型,DRPLA基因(CAG)n正常变异范围存在地区和种族差异,中国大陆DRPLA发病率低可能同正常国人较大重复次数的等位基因少见有关。 相似文献
7.
The underlying cause of a number of autosomal dominant spinocerebellar ataxias is the expansion of various types of simple sequence repeats located in diverse functional regions of different single genes. The genetic heterogeneity of these diseases which contrasts with the similarity of their pathology sites and clinical symptoms justifies the search for the shared mechanism of pathogenesis. In this article we discuss the arguments which are in favor of the RNA-mediated pathomechanism. 相似文献
8.
9.
Anna Sułek-Piątkowska Elżbieta Zdzienicka Maria Rakowicz Wioletta Krysa Marta Rajkiewicz Walentyna Szirkowiec Jacek Zaremba 《Neurologia i neurochirurgia polska》2010,44(3):238-245
Background and purposeAutosomal dominant spinocerebellar ataxias (SCAs) belong to a group of neurodegenerative disorders usually of adult age at onset. Predominant clinical features are progressive ataxia, dysarthria, as well as pyramidal signs and polyneuropathy. Molecular analysis allows particular types of SCA to be distinguished. Genetic tests are applied in 10 types of SCA resulting from dynamic mutations: SCA1, SCA2, SCA3, SCA6, SCA7, SCA8, SCA10, SCA12, SCA17 and DRPLA.Material and methodsDNA samples from 1598 patients with ataxia symptoms were analysed to establish the number of CAG/CTG repeats in respective genes excluding SCA10.ResultsWe diagnosed 224 cases of SCA1 (120 families) and 49 cases of SCA2 (23 families). Moreover, presymptomatic testing was done in 85 individuals from SCA1 families and for 21 cases from SCA2 families. An increased number of CTG repeats in the SCA8 gene was observed in 14 families and in 3 families a rare type of SCA, SCA17, was detected.ConclusionsOur data suggest that frequencies of some types of SCA in Poland are different from those in other European countries, with irregular distribution within the country. The most frequent types are SCA1 and SCA2. A striking feature of the Polish population is the lack of SCA3 – the most frequent type in Western Europe. 相似文献
10.
Nan Zhang Brittani Bewick Jason Schultz Anjana Tiwari Robert Krencik Aijun Zhang Kaho Adachi Guangbin Xia Kyuson Yun Partha Sarkar Tetsuo Ashizawa 《Neurotherapeutics》2021,18(3):1710
CAG repeat expansion is the genetic cause of nine incurable polyglutamine (polyQ) diseases with neurodegenerative features. Silencing repeat RNA holds great therapeutic value. Here, we developed a repeat-based RNA-cleaving DNAzyme that catalyzes the destruction of expanded CAG repeat RNA of six polyQ diseases with high potency. DNAzyme preferentially cleaved the expanded allele in spinocerebellar ataxia type 1 (SCA1) cells. While cleavage was non-allele-specific for spinocerebellar ataxia type 3 (SCA3) cells, treatment of DNAzyme leads to improved cell viability without affecting mitochondrial metabolism or p62-dependent aggresome formation. DNAzyme appears to be stable in mouse brain for at least 1 month, and an intermediate dosage of DNAzyme in a SCA3 mouse model leads to a significant reduction of high molecular weight ATXN3 proteins. Our data suggest that DNAzyme is an effective RNA silencing molecule for potential treatment of multiple polyQ diseases.Supplementary InformationThe online version contains supplementary material available at 10.1007/s13311-021-01075-w. 相似文献
11.
Spinocerebellar ataxia type 17 in the Yugoslav population 总被引:1,自引:0,他引:1
Alendar A Euljković B Savić D Djarmati A Keckarević M Ristić A Dragasević N Kosić V Romac S 《Acta neurologica Scandinavica》2004,109(3):185-187
OBJECTIVES: (1) Analysis of Spinocerebellar ataxia type 17 (SCA17) locus in a group of ataxic patients excluded on other known SCAs; (2) assessment of frequency distributions of SCA17 alleles in the Yugoslav population. MATERIAL AND METHODS: Study includes 115 non-related Yugoslav patients belonging to autosomal-dominant cerebellar ataxias or to sporadic idiopathic adult-onset ataxia and 115 controls. Analysis of SCA17 locus was performed using polymerase chain reaction. RESULTS: None of the analyzed patients show the presence of mutation in SCA17 locus. In the group of patients 12 different alleles in the range of 30-42 repeats were observed, while in healthy population eight alleles in the range of 30-40 repeats were detected. CONCLUSION: (1) None of 115 non-related Yugoslav ataxic patients belong to any known SCAs nor to DRPLA gene; (2) the distribution of SCA17 alleles in the Yugoslav population is consistent with the distribution in other populations and (3) the paucity of alleles with more than 39 repeats could suggest that SCA17 is very rare in the Yugoslav population. 相似文献
12.
目的 探讨我国汉族人群CACNA1A基因CAG重复数目分布特点及其在脊髓小脑性共济失调6型(spinocerebellar ataxias type 6,SCA6)基因诊断中的应用.方法 应用"两步PCR法"、变性聚丙烯酰胺凝胶电泳(DPAGE)和测序等方法对300名健康对照及109例无血缘关系的SCA患者进行CACNA1A基因CAG三核苷酸重复数目分析.结果 300名健康对照的CAG重复次数范围为3~18次,以13次最常见.在109例SCA患者中,发现1例SCA6患者,其CAG异常重复次数为24次,该患者的母亲和哥哥亦为SCA6患者,临床上均表现为缓慢进展的小脑性共济失调、构音障碍、眼震、轻度的振动及本体觉减退,遗传早现现象较明显.结论 SCA6病例在我国较少见,进行CACNA1A基因突变分析有助于临床诊断."两步PCR法"可提高CACNA1A基因突变分析的效率. 相似文献
13.
BackgroundDystonia is a common feature in spinocerebellar ataxias (SCAs). Whether the presence of dystonia is associated with different rate of ataxia progression is not known.ObjectivesTo study clinical characteristics and ataxia progression in SCAs with and without dystonia.MethodsWe studied 334 participants with SCA 1, 2, 3 and 6 from the Clinical Research Consortium for Spinocerebellar Ataxias (CRC-SCA) and compared the clinical characteristics of SCAs with and without dystonia. We repeatedly measured ataxia progression by the Scale for Assessment and Rating of Ataxia every 6 months for 2 years. Regression models were employed to study the association between dystonia and ataxia progression after adjusting for age, sex and pathological CAG repeats. We used logistic regression to analyze the impact of different repeat expansion genes on dystonia in SCAs.ResultsDystonia was most commonly observed in SCA3, followed by SCA2, SCA1, and SCA6. Dystonia was associated with longer CAG repeats in SCA3. The CAG repeat number in TBP normal alleles appeared to modify the presence of dystonia in SCA1. The presence of dystonia was associated with higher SARA scores in SCA1, 2, and 3. Although relatively rare in SCA6, the presence of dystonia was associated with slower progression of ataxia.ConclusionsThe presence of dystonia is associated with greater severity of ataxia in SCA1, 2, and 3, but predictive of a slower progression in SCA6. Complex genetic interactions among repeat expansion genes can lead to diverse clinical symptoms and progression in SCAs. 相似文献
14.
B. Lanzillo A. Perretti L. Santoro L. Pelosi A. Filla G. De Michele G. Caruso 《The Italian Journal of Neurological Sciences》1994,15(1):25-37
A multimodal electrophysiological study, including median nerve somatosensory evoked potentials (SSEPs), motor cortical stimulation
(CS) and brainstem evoked potentials (BAEPs), was performed on 34 patients with hereditary ataxias (HAs): 15 with Friedreich's
disease (FD), 10 with early onset cerebellar ataxia (EOCA), and 9 with autosomal dominant cerebellar ataxia (ADCA). A higher
incidence of abnormal central motor conduction was observed in FD than in EOCA patients, but was never observed in ADCA. A
relationship between central motor conduction abnormalities and disease duration and clinical impairment was found only in
FD patients. All FD patients showed severe impairment of the SSEPs that was not related to disease duration. In EOCA patients,
less frequent and more variable SSEP abnormalities were observed. The lowest incidence of central SSEP abnormalities was observed
in ADCA. The BAEP findings in all 3 groups of patients (but particularly those with EOCA) suggest prevalent brainstem damage.
Sommario Abbiamo sottoposto 34 pazienti affetti da varie forme di eredoatassia [15 con atassia di Friedreich (FD), 10 con atassia cerebellare ad esordio precoce con conservazione dei riflessi (EOCA) e 9 con atassia cerebellare dominante (ADCA)] a stimolazione della corteccia motoria (CS), potenziali evocati somatosensoriali (SSEPs) ed acustici (BAEPs). La via motoria centrale è risultata maggiormente compromessa nei pazienti con FD rispetto a quelli con EOCA mentre nei pazienti con ADCA non è risultata mai coinvolta; le alterazioni osservate sono risultate correlate con la durata e con la gravità della malattia solo nei pazienti con FD. I SSEPs, risultati gravemente compromessi in tutti i pazienti con FD, non presentavano alcuna correlazione con la gravità della malattia. L'incidenza e la gravità delle alterazioni dei SSEPs nei pazienti con EOCA e ADCA è risultata inferiore rispetto a quelli con FD. I BAEPs sono risultati frequentemente alterati nei 3 gruppi di pazienti con una maggiore percentuale negli EOCA.相似文献
15.
Judith van Gaalen MD Paola Giunti MD Bart P. van de Warrenburg MD PhD 《Movement disorders》2011,26(5):792-800
Autosomal dominant spinocerebellar ataxias (SCAs) can present with a large variety of noncerebellar symptoms, including movement disorders. In fact, movement disorders are frequent in many of the various SCA subtypes, and they can be the presenting, dominant, or even isolated disease feature. When combined with cerebellar ataxia, the occurrence of a specific movement disorder can provide a clue toward the underlying genotype. There are reasons to believe that for some coexisting movement disorders, the cerebellar pathology itself is the culprit, for example, in the case of cortical myoclonus and perhaps dystonia. However, movement disorders in SCAs are more likely related to extracerebellar pathology, and imaging and neuropathological data indeed show involvement of other parts of the motor system (substantia nigra, striatum, pallidum, motor cortex) in some SCA subtypes. When confronted with a patient with an isolated movement disorder, that is, without ataxia, there is currently no reason to routinely screen for SCA gene mutations, the only exceptions being SCA2 in autosomal dominant parkinsonism (particularly in Asian patients) and SCA17 in the case of a Huntington's disease–like presentation without an HTT mutation. © 2011 Movement Disorder Society 相似文献
16.
17.
Q. Xu X.H. Li J.L. Wang H. Jiang S. Zhang L.F. Lei L. Shen K. Xia Q. Pan Z.G. Long B.S. Tang 《Journal of clinical neuroscience》2009,16(10):1374-1375
Spinocerebellar ataxia type 17 (SCA17) is a rare autosomal dominant progressive neurodegenerative disease caused by the CAG/CAA expansion in the TATA box-binding protein (TBP) gene. This study aimed to assess the frequency of SCA17 in patients from mainland China. Analysis of CAG/CAA expansion in this gene was performed in 263 patients consisting of 100 probands with dominantly inherited ataxias and 163 patients with sporadic ataxias. Abnormal expansion of CAG/CAA repeats in the SCA17 locus was found in a proband and her younger sister. To our knowledge, we are providing the first kindred analysis of SCA17 in mainland China. 相似文献
18.
Autosomal recessive ataxias are a heterogeneous group of rare neurodegenerative diseases characterized by early onset cerebellar ataxia associated with various neurologic, ophthalmologic and systemic signs. In comparison with autosomal dominant ataxias, the group of recessive ataxias is less extensively characterized. In fact, only a few conditions have been genetically characterized. The pathogenesis of these forms is associated with a "loss of function" of specific cellular proteins involved in metabolic homeostasis, cell cycle, and DNA repair/protection processing. The two most common autosomal recessive ataxias, in European countries, are Friedreich's ataxia and ataxia telangiectasia. Other forms are much less frequent, and include ataxia with vitamin E deficiency, abetalipoproteinemia. Refsum's disease, spastic ataxia, infantile onset spinocerebellar ataxia, and ataxia with oculomotor apraxia. These pathological conditions, although extremely rare, have nevertheless to be carefully considered in differential diagnosis, not only for correct nosographical classification, but particularly, for specific prognostic and therapeutic implications. Some of these diseases exhibit a peculiar regional distribution. An updated review of the clinical, genetic, and pathogenic aspects of recessive ataxias is presented. Specific management problems with respect to diagnosis and genetic counseling are discussed. 相似文献
19.
Spinocerebellar ataxia (SCA) type 7 is an autosomal dominant disorder characterized by neural loss, mainly in the cerebellum and regions of the brainstem and particularly the inferior olivary complex. This neurodegeneration disease is associated with expansion of unstable CAG repeats within the 5'-translated region of the SCA7 gene, located on chromosome 3p. We conducted a local survey of the normal population and candidate patients for the analysis of the CAG repeats in the SCA7 gene. The distributions of the CAG repeat units of SCA7 gene in the normal population in Taiwan were established in this study by using the radioactive genomic polymerase chain reaction (PCR). The normal range of CAG repeats is from 6 to 17 repeats, with the more common being around 8-13 repeats. The range is narrower than that reported for other ethnic groups (7-35 CAGs). Meanwhile, by the use of a combination of PCR and Southern blot analysis, one SCA7 family was identified and is reported here. A marked instability of the CAG repeat number during transmission from father to son (41 vs. 100) was observed in the SCA7 family. Clinical anticipation is significant in this family including an infantile case, who was found to have nystagmus from the age of 1 month. To date, the SCA7 mutation has been detected in one of 73 families with autosomal dominant cerebellar ataxia phenotypes, which is about 1.4% of the ataxia families referred to us, compared to 1.4% SCA1, 9.6% SCA2, and 27.3% SCA3/Machado-Joseph disease in our collection. In addition, we demonstrate that the PCR-based Southern blot analysis, with the advantages of sensitivity of PCR and specificity of Southern blot, is a reliable diagnostic method for SCA7 mutation screening. The molecular analysis technique makes possible the quick and accurate diagnosis of SCA7 patients and in the future will hopefully be applied to prenatal screening for SCA7 families. 相似文献
20.